Oleg Movchan is the Chief Executive Officer of Enfusion. As an Enfusion founding investor, Mr. Movchan played a key role in Enfusion’s early product and technology evolution and was deeply involved in scaling the business over the years. Mr. Movchan has been an Enfusion client at several investment firms and joined the Enfusion Board of Directors in 2021 after serving on the Board of Managers since 2009.
Mr. Movchan’s experience in the asset management, investment banking, and operating industries spans more than 27 years across both public and private capital markets. He previously served as the Chief Risk Officer and Head of Risk Management for multiple asset management firms overseeing hedge funds, fund-of-funds and other investment vehicles, including UBS Global Asset Management, Ritchie Capital Management, Alexandra Investment Management, and Attalus Capital. He is a Founder and Managing Partner of Gimel Tech Ventures, a private equity and venture capital investment platform specializing in applications of technology in financial services, cyber security, real estate, and healthcare.
Additionally, Mr. Movchan is a founding investor in Revolution Global, a vertically integrated consumer packaged goods operating platform. During his tenure (from inception in 2014 through 2021), Mr. Movchan held various senior leadership roles, including Chief Investment Officer, Chief Strategy Officer, Deputy CEO, and Board Member.
A graduate of the General Management Program from Aresty Institute of Executive Education at the University of Pennsylvania’s Wharton School, Mr. Movchan earned a MS in Financial Mathematics and an MBA in Analytic Finance from the University of Chicago. He received a MS in Applied Mathematics and Physics from Kharkov State University, Ukraine. Mr. Movchan also holds a CFA designation.
What is Oleg Movchan's net worth?
The estimated net worth of Oleg Movchan is at least $7.02 million as of March 6th, 2025. Mr. Movchan owns 631,847 shares of Enfusion stock worth more than $7,016,661 as of March 30th. This net worth estimate does not reflect any other assets that Mr. Movchan may own. Additionally, Mr. Movchan receives an annual salary of $834,790.00 as CEO at Enfusion. Learn More about Oleg Movchan's net worth.
What is Oleg Movchan's salary?
How do I contact Oleg Movchan?
Has Oleg Movchan been buying or selling shares of Enfusion?
In the last ninety days, Oleg Movchan has sold $190,537.71 in shares of Enfusion stock. Most recently, Oleg Movchan sold 11,452 shares of the business's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $11.39, for a transaction totalling $130,438.28. Following the completion of the sale, the chief executive officer now directly owns 631,847 shares of the company's stock, valued at $7,196,737.33. Learn More on Oleg Movchan's trading history.
Who are Enfusion's active insiders?
Are insiders buying or selling shares of Enfusion?
During the last twelve months, insiders at the sold shares 29 times. They sold a total of 160,582 shares worth more than $1,648,833.48. The most recent insider tranaction occured on March, 6th when CEO Oleg Movchan sold 11,452 shares worth more than $130,438.28. Insiders at Enfusion own 36.4% of the company.
Learn More about insider trades at Enfusion. Information on this page was last updated on 3/6/2025.
